Cubist Systematic Strategies, LLC Global Blood Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $960,822 - $2.02 Million	-29,655 Reduced 47.46%	32,834 $2.24 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $1.15 Million - $1.93 Million	51,598 Added 473.77%	62,489 $2 Million
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $690,766 - $957,335	-26,899 Reduced 71.18%	10,891 $377,000
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $3.49 Million - $5.64 Million	-140,009 Reduced 78.75%	37,790 $1.11 Million
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $2.37 Million - $3.47 Million	92,896 Added 109.41%	177,799 $4.53 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $235,951 - $315,619	7,269 Added 9.36%	84,903 $2.97 Million
Q1 2021 May 17, 2021	BUY	$38.94 - $50.85 $899,319 - $1.17 Million	23,095 Added 42.35%	77,634 $3.16 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $803,714 - $1.36 Million	21,347 Added 64.31%	54,539 $2.36 Million
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $965,244 - $1.36 Million	-18,295 Reduced 35.53%	33,192 $1.83 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $1.6 Million - $2.69 Million	32,906 Added 177.09%	51,487 $3.25 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $194,748 - $407,049	-4,668 Reduced 20.08%	18,581 $949,000
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $463,580 - $830,387	10,144 Added 77.41%	23,249 $1.85 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $193,054 - $246,522	-4,257 Reduced 24.52%	13,105 $636,000
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $913,241 - $1.1 Million	17,362 New	17,362 $913,000
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $296,791 - $439,164	-9,410 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $49,704 - $66,838	1,308 Added 16.14%	9,410 $358,000
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $313,547 - $406,315	8,102 New	8,102 $366,000
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $29,026 - $48,304	-733 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $171,844 - $264,420	-5,786 Reduced 88.76%	733 $29,000
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $163,626 - $202,414	6,519	6,519 $202,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account